May 14, 2025 May 14, 2025 May 06, 2025

From cosmetic applicator tips, brushes, and compact closure seals to applicator slit valves, fine tips, and airless package pumps, the materials you choose have a major impact.

We also generated 4% and 1% organic sales growth in EMEA and Asia, respectively. https://www.avient.com/investors https://edge.media-server.com/mmc/p/pyh3w2ip/ https://www.avient.com/investors https://register.vevent.com/register/BId7a8a09515a442e9b13c4d5558d927fe https://www.avient.com/investors/events-presentations 4 Non-GAAP Financial Measures The Company uses both GAAP (generally accepted accounting principles) and non-GAAP financial measures. 2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and the establishment, reversal or changes to valuation allowances. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (In millions) (Unaudited) June 30, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 489.4 $ 545.8 Accounts receivable, net 486.6 399.9 Inventories, net 365.9 347.0 Other current assets 117.2 114.9 Total current assets 1,459.1 1,407.6 Property, net 1,019.9 1,028.9 Goodwill 1,685.1 1,719.3 Intangible assets, net 1,515.7 1,590.8 Other non-current assets 228.0 221.9 Total assets $ 5,907.8 $ 5,968.5 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 657.7 $ 9.5 Accounts payable 435.2 432.3 Accrued expenses and other current liabilities 405.3 331.8 Total current liabilities 1,498.2 773.6 Non-current liabilities: Long-term debt 1,420.8 2,070.5 Pension and other post-retirement benefits 63.3 67.2 Deferred income taxes 276.3 281.6 Other non-current liabilities 315.0 437.6 Total non-current liabilities 2,075.4 2,856.9 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,317.5 2,319.2 Noncontrolling interest 16.7 18.8 Total equity 2,334.2 2,338.0 Total liabilities and equity $ 5,907.8 $ 5,968.5 11 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Six Months Ended June 30, 2024 2023 Operating Activities Net income $ 83.5 $ 42.7 Adjustments to reconcile net income to net cash provided (used) by operating activities: Depreciation and amortization 88.4 96.2 Accelerated depreciation 0.8 1.9 Share-based compensation expense 9.0 6.5 Changes in assets and liabilities: Increase in accounts receivable (97.0) (66.6) (Increase) decrease in inventories (27.3) 14.0 Increase (decrease) in accounts payable 11.9 (26.2) Taxes paid on gain on sale of business — (103.0) Accrued expenses and other assets and liabilities, net (6.2) 9.8 Net cash provided (used) by operating activities 63.1 (24.7) Investing activities Capital expenditures (55.8) (45.9) Net proceeds from divestiture — 7.3 Proceeds from plant closures 3.4 — Other investing activities (2.1) — Net cash used by investing activities (54.5) (38.6) Financing activities Cash dividends paid (47.0) (45.0) Repayment of long-term debt (4.5) (1.0) Other financing activities (3.3) (2.3) Net cash used by financing activities (54.8) (48.3) Effect of exchange rate changes on cash (10.2) (0.8) Decrease in cash and cash equivalents (56.4) (112.4) Cash and cash equivalents at beginning of year 545.8 641.1 Cash and cash equivalents at end of period $ 489.4 $ 528.7 12 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

Lin 16,592(4) - 16,592 RRichard A. Outstanding Equity Att wards at 2016 Fiscal Year-End Exercise Price ((e)) Expiration Date ((f))ff Market Value of Shares or Units of Stock That Have Not Vested ((h)) Equity Incentivtt e Plan Awards: Market or Payout Value of Unearned Shares, Units ot r Othertt Rights ttt hatt t Have Not Vested ((jj)) - - 8,510 (1) 272,660 - - - 24,671 (2) 790,459 - - - 35,272 (3) 1,130,115 - - - - 51,756 (6) 1,658,262 - - - 51,756 (6) 1,658,262 30,500 (8) 14.81 2/16/2021 - - 48,800 (9) 14.61 2/14/2022 - - 30,700 (10) 23.08 2//15//2023 - - 13,667 (11) 6,833 (11) 35.07 2//11//2024 - - 66,700 (12) 38.27 2//4//2025 - - 105,200 (13) 24.98 2/10/2026 - - - 7,266 (1) 232,803 - - - 6,892 (2) 220,820 - 8,426 (3) 269,969 - 11,600 (11) 5,800 (11) 35.07 2/11/2024 - 18,700 (12) 38.27 2//4//2025 - - 25,150 (13) 24.98 2//10//2026 - - - - 4,360 (1) 139,694 - - - 25,935 (4) 830,957 - - - 4,114 (2) 131,813 - - - 5,026 (3) 161,033 - - - - 25,935 (7) 830,957 13,700 (10) 23.08 2/15/2023 - - 6,934 (11) 3,466 (11) 35.07 2/11/2024 - - 11,200 (12) 38.27 2/4/2025 - - 15,000 (13) 24.98 2//10//2026 - - - - 3,222 (1) 103,233 - - - 2,593 (5) 83,080 - - - 3,395 (2) 108,776 - - - 4,316 (3) 138,285 5,200 (11) 2,600 (11) 35.07 2/11/2024 - - 9,200 (12) 38.27 2/4/2025 - - 12,900 (13) 24.98 2//10//2026 - - - - 3,634 (1) 116,433 - 3,500 (2) 112,140 - 4,569 (3) 146,391 - 23,300 (9) 14.61 2//14//2022 - - 13,700 (10) 23.08 2/15/2023 - 5,800 (11) 2,900 (11) 35.07 2/11/2024 - - 9,300 (12) 38.27 2/4/2025 - 13,550 (13) 24.98 2//10//2026 - - 37,760 (1) 1,209,830 - 137,000 (10) 23.08 2//15//2023 - 60,667 (11) 30,333 (11) 35.07 2/11/2024 - S.D. B-7 4.

ITEM 4. The table below summarizes restructuring activity related to Brazil since the date of closure. Committees: 1, 2, 4* SANDRA B.

GUIDANCE DEBT / LEVERAGE REDUCTION • Completed sale of Distribution and paid down $750M of debt in November • Strong free cash flow in fourth quarter reduced leverage and enabled paydown of additional $200M of debt • Fixed/Floating Debt Ratio 63/37 • Proven track record of deleveraging following acquisitions through consistent free cash flow generation $725 $725 $725 $575 $500 $400 $600 $525 $425 $650 $650 $650 $600 $2.40B $2.20B 2030 Notes 2029 Term Loan 2026 Term Loan 2025 Notes After Distribution Divestiture Year-End Year-End Leverage 3.8x 3.1x 2.9x 2023 Notes After Avient Protective Materials Acquisition $3.15B 2022 TRANSFORMATIONAL PORTFOLIO ENHANCEMENTS 5 EBITDA margins expanded from 12% to 16% Diversified end markets with reduced exposure to more cyclical industries Dyneema® Acquisition $1.48B acquisition strengthens composites platform Significantly improved EBITDA margins $950M divestiture results in 100% specialty sales Strong exit multiple of 10x TTM EBITDA despite market volatility Distribution Divestiture Improved Portfolio GROWING COMPOSITES PLATFORM CONTRIBUTIONS TO SEM SEGMENT 6 Note: 2022 is pro forma for Avient Protective Materials 2016 Sales 2022 Sales Advanced Composites 51% $560M $1,300M Advanced Composites COMPOSITES PORTFOLIO D Y N E E M A ® E X P A N D S O U R E N G I N E E R E D F I B E R S A N D T A P E S T E C H N O L O G Y LFT Tapes Laminates/Panels Shapes Pultrusion Engineered Fibers 7 ADVANCED COMPOSITES PERFORMANCE 8 (1) Pro forma for the acquisition of Avient Protective Materials $51 $84 $212 $668 $4 $10 $41 $169 (1) (1) PORTFOLIO EVOLUTION AND EPS EXPANSION 9 Adj. EPS $0.14 $2.67 $3.04 TOP-TIER SUSTAINABILITY PERFORMANCE AND RECOGNITION Industry Sustainability Standards 90th percentile 84th ESG Ratings Performance 1 10 PEOPLE C U L T U R E I S E V E R Y T H I N G Community Service 7x Safer than Industry Average World-Class Safety Leadership Development Over $17 million raised since 2010 Diversity & Inclusion 11 2022 RE SU LT S Q4 EBITDA BRIDGE (PRO FORMA TOTAL COMPANY) 13 $ millions CAI: Price / Mix 42 Inflation (20) SEM: Price / Mix 14 Inflation (10) Net Price Benefit 26 Wage and Energy Inflation (13) Clariant Color Integration Synergies 4 Incentives, Other Employee Costs 21 FX (10) Q4 2022 $107 Adjusted Q4 2021 $ 132 Demand (50) Russia Import Sales (3) • Demand contraction especially prevalent in EMEA and Asia • Pricing continues to cover inflation of raw materials, wages and energy PROVEN TRACK RECORD OF STRONG AND IMPROVING FREE CASH FLOW GENERATION 14 • Periods of economic weakness have driven higher levels of cash generation due to working capital management • Anticipate continued strong free cash flow generation and conversion despite global uncertainty 78% 78% 80% 80% 81% 78% 84% 83% 80% 0% 30% 40% 50% 60% 70% 80% 90% 2014 2015 2016 2017 2018 2019 2020 2021 2022 0 50 100 150 200 250 300 350 400 re e as h F lo w C o n ve rs io n re e as h F lo w FCF $ AVNT FCF Conversion % S&P FCF Conversion % Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA. 2020 is pro forma for Clariant Color and 2022 is pro forma for Avient Protective Materials $600 $592 $3.02 $3.04 FULL YEAR 2022 PERFORMANCE (TOTAL COMPANY PRO FORMA) 15 Sales Adjusted EBITDA $3,712 $3,653 -2% Adjusted EPS -1% + 1% (in millions) (in millions) (+4% excluding FX) (+5% excluding FX) (+9% excluding FX) FULL YEAR 2022 SEGMENT PERFORMANCE 16 CAI $2,402 $2,355 $409 $402 SEM Pro Forma $1,308 $1,300 $278 $272 (+4% excluding FX) - 2% -1% (+5% excluding FX) - 2% (+4% excluding FX) - 2% (+2% excluding FX) PRO FORMA FULL YEAR EPS BRIDGE 17 Pro Forma 2021 Adjusted EPS 3.02$ Foreign Currency (0.23) Russia Import Sales (0.07) Outdoor High Performance (0.13) Color, Additives and Inks 0.18 Specialty Engineered Materials 0.24 Corporate Costs / Other 0.03 Pro Forma 2022 Adjusted EPS 3.04$ FULL YEAR EBITDA BRIDGE (PRO FORMA TOTAL COMPANY) 18 $ millions CAI: Price / Mix 247 Inflation (176) SEM: Price / Mix 121 Inflation (77) Net Price Benefit 115 Wage and Energy Inflation (47) Clariant Color Integration Synergies 23 Incentives, Other Employee Costs 43 FX (34) Full Year 2022 $592 Adjusted Full Year 2021 $ 600 Demand (99) Russia Import Sales (9) • Demand primarily impacted by China lockdowns, 4th quarter industrywide destocking and declining consumer sentiment • Pricing outpaced inflation of raw materials, wages and energy 2023 G U IDA N CE $125 $530 $0.55 $2.40 2023 GUIDANCE 20 Sales Adjusted EBITDA $845 $3,450 Adjusted EPS (in millions) (in millions) CASH FLOW / BALANCE SHEET 21 • IT investment to further integrate acquired businesses and capture operational efficiencies • Restructuring actions to streamline operations and improve profitability, primarily in Europe ($ millions) 2023E Cash Flow from Operating Activities 350$ Less: Run-Rate CapEx (110) CapEx for IT System Upgrade (25) CapEx for Restructuring (15) Total CapEx (150) Free Cash Flow 200$ Adjusted EBITDA 530$ Net Debt / Adjusted EBITDA 2.9x K E Y G R O W T H D R I V E R S A N D T R A N S F O R M E D P O R T F O L I O GROWTH DRIVERS: PROVEN SUCCESS 23 (1) Pro forma for the acquisition of Avient Protective Materials (APM) COMPOSITES $51 $84 $212 $668 HEALTHCARE $108 $113 $231 $293 8-10% ASIA/EMERGING REGIONS $265 $358 $726 $830 12% $340 $455 $790 $1,175 SUSTAINABLE SOLUTIONS 8-12% (1) (1)(1) (Sales in $ millions) #1 Color Formulator Dyneema® - World’s Strongest Fiber™ #1 in Composites applications for outdoor high performance #1 in Performance Inks Customized solutions 140+ PhDs on staff Rapid development of innovative products Extensive patent (2,500+) portfolio 33% Vitality Index Better-positioned toward stable, high-growth end markets Consumer, packaging, healthcare and defense comprise nearly 60% of sales Agnostic to raw materials, helping all customers achieve their goals Broad portfolio of diversified sustainable solutions 90%+ of our innovation pipeline invested in sustainable solutions Long-term growth rate well above GDP with expectations of 8-12% LEVERAGING OUR TRANSFORMED PORTFOLIO 24 Building & 4% Telecom. 2022 PF $3.65B sales Leading Positions Sustainable SolutionsDiversified IndustriesSpecialty Formulator (1) 2022 Pro forma for the acquisition of Avient Protective Materials (2) 2020 Pro forma for the acquisition of Clariant Color (1)(2) $340M $455M $790M 2016 2018 2020PF 2022PF $1,175M P EE R C O M PAR IS O N S AVIENT IS ASSET LIGHT Capex / Revenue 2023E (%) Avient Specialty Other Specialty / Note: Avient reflects 2023 estimated revenue of $3,450 and estimated run-rate CAPEX of $110M. 27 2 4 4 5 5 5 6 7 7 FREE CASH FLOW CONVERSION Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA.

Eastern Time Record Date Voting Matters and Vote Recommendations Proposals For Your Vote Board Recommendation 1 2 3 4 Lisa K. All Other Stock Awards: Number of Shares of Stock or Units (RSUs) (column (h)) (4) Annual Grant of RSUs. Section 3 Section 4(d)( ) Section 5 (k) (l) (m) 5.

May 14, 2025 May 14, 2025 May 06, 2025

Nutritional components in dairy products are photosensitive, making them susceptible to light degradation • Light protection in dairy packaging helps maintain product integrity and extend shelf life A LIGHT BLOCKING SOLUTION THAT PROVIDES: • Light blocking and whiteness in PET dairy packaging • Protection from 2 weeks up to 12 months shelf life • Compatibility with monolayer and multilayer PET preforms • Full compatibility with rPET • Food contact approved (region dependent) • Low TiO₂ levels to increase recyclability, aligning with the emergence of white recycle streams PASTEURIZED MILK Typical shelf life 5–10 days WHITE COLOR LACTRA ESL LACTRA SX or LACTRA 4 EXTENDED SHELF LIFE MILK 2 weeks–3 months UHT MILK & PRODUCTS 4–12 months Lightweighting/CO2 reduction Reduced LDR – material & cost savings Improved processing performance BENEFITS OF COLORMATRIX™ LACTRA™ Improved bottle Compatibility with rPET Helps to Protect Performance Energy efficiency Whiteness 85–92 L* 30% less life cycle emissions Increased machinery life cycle due to reduced wear & tear 80–100% light blocking © 2024, All Rights Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012

Additionally, TPEs help to generate lead-time enhancements and feed into capacity utilization improvements. 3© 2020 Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 3. In addition, when used to produce easy-open pill bottles in various colors that can be clearly identified, TPEs aid arthritic patients while they self- administer medications at home. 4. Medical grade TPEs have extremely low levels of leachables and extractables, and are available in several different formulations to address specific processing and end product requirements. 4© 2020 Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 CASE IN POINT: STOPPERS AND SEPTUMS Versaflex™ HC TPE from Avient offers customers an exceptional alternative to rubber for septums and stoppers.